Results 131 to 140 of about 420,370 (213)

End-Diastolic Forward Flow Through the Pulmonic Valve in Carcinoid Heart Disease. [PDF]

JACC Case Rep
Hoyek K, Zalaquett Z, Collier P, Burbano-Vera N, Mehta A.   +4 more
europepmc   +1 more source

Hemodynamic Changes After Transcatheter Valve Repair and Replacement for Tricuspid Regurgitation. [PDF]

J Am Heart Assoc
Alabdaljabar MS, Elhadi M, Thaden JJ, Padang R, Pislaru SV, Hibbert BJ, Simard TJ, Alkhouli MA, Guerrero ME, Rihal CS, Eleid MF.   +10 more
europepmc   +1 more source

TRI-SCORE based risk stratification across contemporary treatment strategies for isolated tricuspid regurgitation: a multicenter retrospective analysis. [PDF]

Front Cardiovasc Med
Gharehdaghi S, Rosseel L, Beles M, Vanderheyden M, Stockman B, Casselman F, Mistrulli R, Degrieck I, Van Praet K, Spapen J, Brouwers S, Van Praet F, Penicka M, Van Camp G.   +13 more
europepmc   +1 more source

TricValve System Implantation in Patients With Cardiac Implantable Electronic Devices: A Multicentre Observational Study. [PDF]

Eur J Cardiothorac Surg
Osipenko K, Coti I, Werner P, Kahrovic A, Franco LN, Amat Santos IJ, Mahabadi AA, Frerker C, De Marco F, Althoff J, Mangieri A, Moreiras JM, Pavlović N, Schofer J, Schäfer U, Tigges E, Wilde C, Hausleiter J, Altisent OA, Taramasso M, Valbuena LFP, Bulum J, Ordoñez S, Swaans M, Marques JS, Dickmann B, Zirngast B, Zimpfer D, Andreas M.   +28 more
europepmc   +1 more source

TCT-676 Prevalence of Residual Mitral and Tricuspid Regurgitation (MR/TR) following Transcatheter Aortic Valve Replacement (TAVR): Residual Mod/Severe MR and TR is Associated with Higher Mortality post TAVR

Journal of the American College of Cardiology, 2016
John Schindler, Joao Cavalcante, Andrew Althouse, Michael S. Sharbaugh, Dustin Kliner, William Katz, Matthew E. Harinstein, Frederick W. Crock, Forozan Navid, Joon Lee, Thomas Gleason   +10 more
openaire   +1 more source

Effect of empagliflozin with or without carvedilol on tricuspid regurgitation and right ventricular remodeling: PROVE trial. [PDF]

J Cardiovasc Imaging
Kim GY, Lim SM, Yang DH, Lee JE, Lee S, Park SJ, Hwang IC, Yoon YE, Shim CY, Kim HK, Yun SC, Song JM, Kang DH.   +12 more
europepmc   +1 more source

Severe Functional Tricuspid Regurgitation Masked by Annular Deformation in Primary Cardiac Lymphoma. [PDF]

JACC Case Rep
Tanahashi T, Moribayashi K, Matsuura Y, Yamamoto K, Tanaka H, Komaki S, Kisanuki A, Yamashita A, Watanabe N, Kaikita K.   +9 more
europepmc   +1 more source

Reversible Right-to-Left Shunt After Mitral TEER Resolved by Tricuspid TEER. [PDF]

JACC Case Rep
Önder Ö, Akhundova A, Güler E.
europepmc   +1 more source

FuTURe Study (FUnctional Tricuspid Update Study of REcurrence)-Personalized Risk Stratification for Functional Tricuspid Regurgitation Recurrence After Mitral-Tricuspid Surgery. [PDF]

J Clin Med
Grandinetti M, Mazzenga G, Bruno P, Chiariello GA, Pasquini A, Calabrese M, Testa N, Nesta M, Filice M, Lillo R, Cammertoni F, Pavone N, Burzotta F, Massetti M.   +13 more
europepmc   +1 more source

Minimizing tricuspid valve damage during neonatal patent ductus arteriosus closure by implementing a change in procedural technique. [PDF]

Ann Pediatr Cardiol
Iskander C, Kucuk M, Franco SR, Leahy R, Zablah JE, Morgan GJ.   +5 more
europepmc   +1 more source